Maharshi Badri Pharmaceuticals Private Limited, a active private limited company, was established on 09 April 2007 in Jaipur, Rajasthan, India. Engaging in online healthcare product retail within the manufacturing sector, it holds CIN: U24232RJ2007PTC024162. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹4.50 M and a paid-up capital of ₹2.00 M.
It upholds a compliant status. Its leadership includes Sanjay Kumawat (Director), Madan Lal (Director), Uday Singh (Director). Past directors included Anil Rao Kshirsagar, Manish Kumawat, Sanjay Kumawat. It holds ₹1.25 Cr open charges and ₹4.44 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Vaid Bhawan, Shilp Colony, Khatipura Road, Jhotwara,, Jaipur, Rajasthan, 302012.
U24232RJ2007PTC024162
024162
09 April 2007
₹4.50 M
₹2.00 M
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Maharshi Badri Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Kumawat | Director | 01 Apr 2023 | Current |
| Madan Lal | Director | 01 Dec 2016 | Current |
| Uday Singh | Director | 09 Apr 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Dec 2016 | Past |
| Pramod Abcsdd | Director | 08 Jan 2008 | Past |
| Pramod Abcsdd | Director | 01 Apr 2019 | Past |
| Pramod Abcsdd | Director | 08 Jan 2008 | Past |
| Pramod Abcsdd | Director | 25 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Maharshi Badri Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.52% increase. The company also saw a substantial improvement in profitability, with a 14.82% increase in profit. The company's net worth moved up by a moderate rise of 7.39%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Maharshi Badri Pharmaceuticals had a public holding of 47.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹12,500,000.00
₹4,440,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2024 | Others | ₹1.25 Cr | Open |
| 31 Oct 2012 | Punjab National Bank | ₹4.00 M | Satisfied |
| 02 Jul 2010 | Punjab National Bank | ₹0.44 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Maharshi Badri Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Maharshi Badri Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maharshi Badri Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others amounted to Rs. 12.50 M with Charge ID 100995885 was registered on 30 Sep 2024. was completed.
Maharshi Badri Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Maharshi Badri Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur. was recorded as a recent event.
The activity A charge registered on 31 Oct 2012 via Charge ID 10385335 with Punjab National Bank was fully satisfied on 20 Feb 2024. was completed.
The activity A charge registered on 02 Jul 2010 via Charge ID 10230527 with Punjab National Bank was fully satisfied on 20 Feb 2024. was completed.
The activity Sanjay Kumawat was appointed as a Director was appointed as a Director on 01 Apr 2023 & has been associated with this company since 2 years 8 months . was completed.
The CIN of Maharshi Badri Pharmaceuticals Private Limited is U24232RJ2007PTC024162.
Maharshi Badri Pharmaceuticals Private Limited is headquartered at Vaid Bhawan, Shilp Colony, Khatipura Road, Jhotwara,, Jaipur, Rajasthan, 302012.
Maharshi Badri Pharmaceuticals Private Limited was incorporated on 09 April 2007.
The current directors of Maharshi Badri Pharmaceuticals Private Limited are
The primary industry of Maharshi Badri Pharmaceuticals Private Limited is Manufacturing.
Maharshi Badri Pharmaceuticals Private Limited is unlisted.
The authorized capital of Maharshi Badri Pharmaceuticals Private Limited is ₹4.50 M, and the paid-up capital is ₹2.00 M.
The compliance status of Maharshi Badri Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX